Errichetti, E.; Wolf, P.; Khattri, S.; Gorecki, P.; Miller, M.; Jiang, J.; Han, C.; Kirby, B. Patients With Persistent Mild Psoriasis After Treatment With Ustekinumab Achieved Greater Improvements in Skin Clearance and Patient-Reported Outcomes After Switching to Guselkumab in the Phase 3 NAVIGATE Trial. Acta Derm Venereol 2024, 104, adv41053.